Cynata Therapeutics Ltd
OTC:CYYNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cynata Therapeutics Ltd
OTC:CYYNF
|
AU |
|
P
|
Panchsheel Organics Ltd
BSE:531726
|
IN |
|
T
|
Thaire Life Assurance PCL
SET:THREL
|
TH |
|
A
|
Aegean Airlines SA
LSE:0OHY
|
GR |
|
T
|
Telstra Corporation Ltd
OTC:TTRAF
|
AU |
|
T
|
Telefonica SA
OTC:TEFOF
|
ES |
|
Gold Fields Ltd
F:EDGA
|
ZA |
|
Brunello Cucinelli SpA
OTC:BCUCF
|
IT |
|
Barito Pacific Tbk PT
F:OB8
|
ID |
|
Distribution Solutions Group Inc
NASDAQ:DSGR
|
US |
|
Y
|
YM Tech Co Ltd
KOSDAQ:273640
|
KR |
|
U
|
United Tractors Tbk PT
OTC:PUTKF
|
ID |
|
S
|
SLB NV
XHAM:SCL
|
US |
|
CTEK AB (publ)
STO:CTEK
|
SE |
|
AT & S Austria Technologie & Systemtechnik AG
F:AUS
|
AT |
|
E
|
European Lithium Ltd
SWB:PF8
|
AU |
|
Bravida Holding AB
F:BV0
|
SE |
Bankruptcy Probability
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cynata Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Cynata Therapeutics Ltd
ASX:CYP
|
2.5m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cynata Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.